Abstract submission date is extended till 30th September 2026
Conference Schedule
Scientific Program
Browse conference days, sessions, speakers, venues, oral presentations and poster sessions. Program is subject to change until final publication.
Program subject to change. Last updated: 23 Oct 2026, 11:36 AM.
Day 1
-
29 Oct 2026
17
Sessions
08:30
-
21:30
Inaugural Session
Main Auditorium
Time
Talk
Speaker / Presenter
09:00
-
09:05
Welcome of Delegates
TBA
09:05
-
09:11
Lamp lighting & invocation
TBA
09:11
-
09:17
Vande Mataram
TBA
09:17
-
09:23
Welcome address- Convenors of CCI
TBA
09:23
-
09:31
About CCI 2026 — Organising Secretary's report
TBA
09:31
-
09:39
Address by the Patron
TBA
09:39
-
09:47
Addresses by the co-organising institutions
TBA
09:47
-
09:57
Address by the Guest of Honour
TBA
09:57
-
10:12
Inaugural address by the Chief Guest
TBA
10:12
-
10:17
Release of Abstract book
TBA
10:17
-
10:24
Vote of thanks
TBA
10:24
-
10:30
National Anthem
TBA
Keynote Lecture I
Main Auditorium
Time
Talk
Speaker / Presenter
10:30
-
11:00
Accelerating precision cancer therapies for rare cancers with the AI-enabled CureSeek platform
Dr. Santosh Kesari
Inauguration of the Bali Manuscript Exhibition, followed by tea
Exhibition area
11:30
-
13:10
Invited Talk
Session 1
Main Auditorium
Chairs: Dr. Gulshan Dhingra, Dr. Umesh Yadav
Time
Talk
Speaker / Presenter
11:30
-
11:50
The ATF5-dependent mitochondrial unfolded protein response coordinates oncogenic fate
Prof. Jerry Edward Chipuk
11:50
-
12:10
Mitochondrial unfolded protein response in neuroendocrine prostate cancer
Prof. Dhyan Chandra
Roswell Park Comprehensive Cancer Center, USA
12:10
-
12:30
Novel metabolic vulnerabilities to metastatic pancreatic cancer
Prof. Pankaj K. Singh
12:30
-
12:50
Can gut microbes guide/help us through breast cancer prevention and treatment?
Prof. Dipali Sharma
12:50
-
13:10
Targeting phospholipid scramblases and phosphatidylserine externalisation in the tumour microenvironment
Prof. Raymond Birge
14:00
-
15:20
Invited Talk
Session 2
Main Auditorium
Chairs: Prof. Abhimanyu Jha, Dr. Ram Babu
Time
Talk
Speaker / Presenter
14:00
-
14:20
Resistin-driven STAT3 activation and exosomal miR-143/145 link chronic psychosocial stress to aggressive breast cancer
Prof. Seema Singh
14:20
-
14:40
Cardiovascular toxicity of cancer therapy: from mechanisms to clinical care
Dr. Sivareddy Kotla
14:40
-
15:00
TAK1 drives rhabdomyosarcoma growth by sustaining stemness and blocking myogenic differentiation
Prof. Ashok Kumar
15:00
-
15:20
Title to be announced
Prof. Amit Awasthi
15:20
-
15:40
Invited Talk
Special Lecture
Main Auditorium
Time
Talk
Speaker / Presenter
15:20
-
15:40
Medicinal Manuscripts in Bali (Indonesia)
TBA
16:00
-
17:20
Invited Talk
Session 3A
Hall A
Chairs: Prof. Paulraj, Dr. Bhuvnesh Kumar
Time
Talk
Speaker / Presenter
16:00
-
16:20
Title to be announced
Prof. Dil Afroze
16:20
-
16:40
Sensing cancer, shaping precision medicine: biosensor innovations for early diagnosis
Prof. Sudha Srivastava
Jaypee Institute of Information Technology, India
16:40
-
17:00
Targeting oncogenic p53 mutants: comprehensive study of p53-stabilising agents for breast cancer treatment
Dr. Manzoor Ahmad Mir
University of Kashmir, India
17:00
-
17:20
Strategies for treatment of wastewater generated from cancer hospitals
Dr. Kashyap Kumar Dubey
16:00
-
17:15
Invited Talk
Session 3B
Hall B
Chairs: Dr. Ravi Mehrotra, Dr. Meenakshi Upreti
Time
Talk
Speaker / Presenter
16:00
-
16:15
Epigenetic targeting of therapy resistance in female cancers: from mechanism to clinical implication
Prof. Pallavi Agarwal
Amity Institute of Molecular Medicine and Stem Cell Research, Amity University, Noida, India
16:15
-
16:30
Mitochondrial roadmap from fission to precision therapy in breast cancer
Dr. Lokendra Kumar Sharma
16:30
-
16:45
AMPKγ subunit switching in response to temozolomide-induced stress drives adaptive signalling in glioblastoma
Dr. Bhawana Bissa
Central University of Rajasthan, India
16:45
-
17:00
Beyond tumour immunity: B-cell metabolic reprogramming in colorectal cancer-associated cachexia
Dr. Jyotirmaya Behera
Kusuma School of Biological Sciences, IIT Delhi, India
17:00
-
17:05
Discussion
TBA
17:05
-
17:15
Access the Full Richness of Biological Complexity with Single Cell and Spatial Multiomics
Dr. Benson Lim
Senior Science and Technology Advisor, Southeast Asia, 10x Genomics
17:20
-
18:40
Invited Talk
Session 4A
Hall A
Chairs: Prof. Rupesh Chaturvedi, Prof. Amit Singh
Time
Talk
Speaker / Presenter
17:20
-
17:40
Targeting the Hippo pathway in cancers
Dr. Ramesh Kumar
A*STAR Institute of Molecular and Cell Biology, Singapore
17:40
-
18:00
MASTL at the nexus of cell-cycle control and breast cancer progression: decoding its oncogenic interactome
Dr. Gauri Misra
National Institute of Biologicals, Greater Noida, India
18:00
-
18:20
3D tumour tissue analogs of H3K27M-altered DIPG: decoding tumour–stromal dynamics and drug response
Dr. Meenakshi Upreti
18:20
-
18:40
Sphingosine-1-phosphate: a crucial molecular driver of metabolic adaptation and immune escape in T-cell lymphoma
Dr. Ajay Kumar
Banaras Hindu University, India
17:20
-
18:40
Invited Talk
Session 4B
Hall B
Chairs: Prof. Radheyshyam Sharma
Time
Talk
Speaker / Presenter
17:20
-
17:35
Reprogramming antitumour immunity: targeting eEF2K signalling and engineering beneficial bacteria for cancer immunotherapy
Dr. Jugal Kishore Das
17:35
-
17:50
Melanoma cells moonlighting as phagocytes
Dr. Shruthy Suresh Aggarwal
17:50
-
18:05
EDIL3 as a novel therapeutic target to overcome vascular immune exclusion in melanoma
Dr. Saba Tabasum
Dana-Farber Cancer Institute, Harvard Medical School, USA
18:05
-
18:20
Blockade of the CXCL-3–CXCR-2 axis normalises tumour vasculature and enhances immune surveillance in triple-negative breast cancer
Dr. Suboj Babykutty
Mar Ivanios College (Autonomous), Thiruvananthapuram, India
18:20
-
18:35
Integrated physics-informed and AI-driven discovery of small-molecule and de novo peptide modulators targeting CTLA-4 for cancer immunotherapy
Dr. Arun Bahadur Gurung
Computational and Mathematical Biology Centre, THSTI, India
18:35
-
18:40
Discussion with the chairs
TBA
Changeover / freshen up
Venue TBA
Cultural Programme
Auditorium
Day 2
-
30 Oct 2026
13
Sessions
08:30
-
21:00
Keynote Lecture II
Main Auditorium
Chairs: Dr. B.C. Das, Dr. Rekha Puria
Time
Talk
Speaker / Presenter
09:00
-
09:30
Bridging targeted protein degradation and antibody conjugates: the next evolution of the ADC platform
Dr. Susanta Samajdar
09:30
-
11:10
Invited Talk
Session 5
Main Auditorium
Time
Talk
Speaker / Presenter
09:30
-
09:50
DARPP-32 is a novel regulator of M2-macrophage polarisation: sustains STAT6 phosphorylation by directly binding and inhibiting tyrosine phosphatase SHP-1
Dr. Arun K Trivedi
09:50
-
10:10
Inhibiting MCU-mediated mitochondrial calcium uptake prevents neurodegeneration and cognitive decline in Alzheimer's disease
Dr. Pooja Jadiya
10:10
-
10:30
Interrogating drug-tolerant states in embryonal rhabdomyosarcoma
Prof. Reshma Taneja
10:30
-
10:50
GPR56 — a regulator of alternative splicing in prostate cancer
Prof. Gargi Bagchi Bhattacharjee
10:50
-
11:10
To be announced
TBA
11:30
-
13:10
Invited Talk
Session 6
Main Auditorium
Chairs: Prof. Radheyshyam Sharma, Dr. Bhaswati Banerjee
Time
Talk
Speaker / Presenter
11:30
-
11:50
Identifying regulators of macropinocytosis in pancreatic cancer
Prof. Priyabrata Mukherjee
11:50
-
12:10
Designing personalised cancer vaccine immunotherapy amidst tumour heterogeneity
Prof. Chandi C. Mandal
Central University of Rajasthan, India
12:10
-
12:30
Novel NHEJ inhibitors for enhancing radiotherapy and chemotherapy
Prof. Sathees C. Raghavan
12:30
-
12:50
FLASH Radiotherapy for Abdominal Malignancies: Beyond the Stem and Stroma
Prof. Subhrajit Saha
12:50
-
13:10
Pancreatic steatosis drives neurogenesis and pancreatic cancer
Dr. Prasenjit Dey
13:10
-
15:00
Poster Presentation
Lunch & Poster Session
Poster Area
Keynote Lecture III
Main Auditorium
Time
Talk
Speaker / Presenter
15:00
-
15:30
Iron addiction as a requirement for epigenetic plasticity in cancer
Dr. Konstantin Salnikow
15:30
-
16:20
Panel Discussion
Panel Discussion
Main Auditorium
16:40
-
18:25
Young Researcher
Session 7A
Hall A
Chairs: Prof. Ram Sagar, Prof. Arttatrana Pal, Dr. Shakti Sahi
Time
Talk
Speaker / Presenter
16:40
-
16:50
To be announced
TBA
16:50
-
17:00
To be announced
TBA
17:00
-
17:10
To be announced
TBA
17:10
-
17:20
To be announced
TBA
17:20
-
17:27
To be announced
TBA
17:27
-
17:34
To be announced
TBA
17:34
-
17:41
To be announced
TBA
17:41
-
17:48
To be announced
TBA
17:48
-
17:55
To be announced
TBA
17:55
-
18:02
To be announced
TBA
18:02
-
18:09
To be announced
TBA
18:09
-
18:16
To be announced
TBA
18:16
-
18:23
To be announced
TBA
18:23
-
18:25
Judges' wrap-up
TBA
16:40
-
18:20
Invited Talk
Session 7B
Main Auditorium
Chairs: Dr. Vijay Mohan, Dr. Nagendra Singh
Time
Talk
Speaker / Presenter
16:40
-
17:00
Reactivation of PAX9 as a tumour suppressive mechanism in oral squamous cell carcinoma
Prof. Sujit K. Bhutia
17:00
-
17:20
Targeting the SETD5–EGFR axis by an isolated fraction of Withania somnifera fruit to suppress EGFR stability and temozolomide resistance in glioma cells
Dr. Ajay Kumar Yadav
Dr. B. R. Ambedkar Center for Biomedical Research, University of Delhi, India
17:20
-
17:40
Deciphering the KLF switch in cancer: from molecular mechanisms to therapeutic potentials
Prof. Sarika Chaudhary
Bennett University, India
17:40
-
18:00
Bacopaside II-mediated disruption of the NRF2–IDH1 axis mediates inhibition of glioblastoma progression via dual regulation of redox homeostasis and metabolic reprogramming
Dr. Biswarup Basu
18:00
-
18:20
A CTCF-metabolic axis reprograms co-transcriptional alternative splicing in breast cancer
Prof. Sanjeev Shukla
Free time / transfer
Venue TBA
Day 3
-
31 Oct 2026
14
Sessions
07:00
-
20:35
Coaches depart Gautam Buddha University for Shiv Nadar University
Venue TBA
Travel
Registration & breakfast at Shiv Nadar University
Dining hall
Welcome session
Venue TBA
Keynote Lecture IV
Main Auditorium
Chairs: Prof. Ravi Verma, Dr. Sorab Dalal
Time
Talk
Speaker / Presenter
09:00
-
09:30
The importance of sex as a biological variable in cancer: impact on the glioblastoma immune response and identification of new therapeutic opportunities
Prof. Justin Lathia
09:30
-
11:10
Invited Talk
Session 8
Main Auditorium
Time
Talk
Speaker / Presenter
09:30
-
09:50
Understanding the role of BLM in B-cell development led to determining its potential in curing B-cell malignancies
Dr. Sagar Sengupta
09:50
-
10:10
Mitochondrial mediator of venetoclax cardiotoxicity in AML
Dr. Dhanendra Tomar
10:10
-
10:30
Designing personalised cancer vaccine immunotherapy amidst tumour heterogeneity
Prof. Periasamy Selvaraj
Emory University School of Medicine, USA
10:30
-
10:50
NF-κB bypasses p53-mediated inhibition of G6PD to promote pentose phosphate pathway activity in cancer
Dr. Nazir Dar
University of Kashmir, India
10:50
-
11:10
Turning off the metastatic switch: targeting tissue RAS in gastric cancer
Dr. Debanjan Chakroborty
Tea
Foyer
Group Photograph
11:30
-
12:50
Invited Talk
Session 9
Main Auditorium
Chairs: Dr. Sagar Sengupta, Dr. Nitin Bharadwaj
Time
Talk
Speaker / Presenter
11:30
-
11:50
Integrated transcriptomic approach to decipher microRNAs, circular RNAs and long non-coding RNAs driven regulatory mechanisms in breast cancer
Dr. Virendra Singh
School of Biotechnology, JNU, New Delhi, India
11:50
-
12:10
Autophagy as a potential target in colorectal cancer
Dr. Sorab Dalal
12:10
-
12:30
Title to be announced
Dr. Anurag Varshney
12:30
-
12:50
From fat to fuel: how obesity supports breast cancer
Dr. Chandrani Sarkar
13:40
-
15:25
Invited Talk
Session 10
Main Auditorium
Chairs: Prof. Girish Kumar, Dr. Navin Kumar
Time
Talk
Speaker / Presenter
13:40
-
13:55
De novo rational design and precision engineering of cancer-targeted multimodal imaging contrast agents for advanced oncologic diagnostics
Dr. Samit Guha
13:55
-
14:10
Astrocyte-specific reduction of p-eIF2α restores protein synthesis and protects neuronal function in the brain tumour microenvironment
Dr. Vijendra Sharma
University of Windsor, Ontario, Canada
14:10
-
14:25
Overcoming therapeutic resistance in renal cell carcinoma: from c-Met–AXL crosstalk to targeted receptor degradation
Dr. Akash Sabarwal
14:25
-
14:40
Flavonoid-loaded chitosan nanoparticles as a therapeutic approach against glioblastoma
Dr. Vibhuti Joshi
Bennett University, India
14:40
-
14:55
Prospective organoid drug profiling and clinical response correlation for patients with primary or recurrent ovarian carcinoma in the PROSPERITY study
Dr. Payel Chatterjee
Cure First, India
14:55
-
15:10
Development of a neuroelectronic interface for detecting impaired neural networks in brain tumours
Dr. Ranjita Ghosh Moulick
Amity University Haryana, India
15:10
-
15:25
Prognostic relevance of cell type-dependent Toll-like receptor 4 expression in triple-negative breast cancer
Dr. Nupur Mukherjee
ICMR–National Institute for Research on Women's Health, India
15:25
-
16:35
Invited Talk
Session 11
Main Auditorium
Chairs: Dr. Imteyaz Qamar, Prof. Ashutosh Singh
Time
Talk
Speaker / Presenter
15:25
-
15:45
BMI1: a journey from bench to the bedside
Prof. Resham Bhattacharya
15:45
-
16:05
Title to be announced
Dr. Shilpee Dutt
16:05
-
16:25
Translating focused ultrasound and nanomedicines for One-Medicine
Dr. Ashish Ranjan
16:25
-
16:35
Finer Details, Bigger Insights: The Art of Sample Preparation for High-Resolution Electron Microscopy
Dr. Indu
Leica
16:55
-
18:05
Invited Talk
Session 12
Main Auditorium
Chairs: Dr. Jai Muyal, Prof. Sanjeev Galande
Time
Talk
Speaker / Presenter
16:55
-
17:15
Healing Health–Total: a digital community-to-care model for early cancer detection and patient navigation in rural Odisha
Prof. P. K. Swain
2HT Foundation, India
17:15
-
17:35
Transcriptional targeting of pancreatic cancer
Dr. Surendra Kumar Shukla
17:35
-
18:05
Epigenetic regulation of oral cancer: implications in diagnostics and therapeutics
Prof. Tapas Kumar Kundu
18:05
-
19:05
Valedictory
Valedictory Session
Main Auditorium
21st International Conference on Emerging Frontiers in Cancer Research brings researchers, clinicians, speakers and delegates together for translational oncology, innovation and collaboration.
Day 1-2: Gautam Buddha University, Greater Noida
Day 3: Shiv Nadar Institute of Eminence, Deemed to be University, Greater Noida
Organised and managed by Labify
This conference is being organised in association with Labify, Samviti Private Limited. Labify is also responsible for managing the official conference website and publishing conference updates, registration information, abstract submission details, programme announcements, payment collection, and delegate support information as they become available.
© 2026 Cancer Conference of India. Website by Global Web Technologies LLP .